An endometrial stromal sarcoma cell line with the JAZF1/PHF1 chimera

Cancer Genetics and Cytogenetics
Ioannis PanagopoulosConstance A Griffin

Abstract

Endometrial stromal sarcomas (ESS) are rare malignancies, accounting for less than 10% of uterine sarcomas. Apart from the chromosomal rearrangement t(7;17)(p15;q21), which leads to the JAZF1/SUZ12 chimera, cytogenetic studies have shown that the chromosome band 6p21 is often rearranged in ESS. The translocation partners involved in the 6p21 rearrangements differ among the tumors, but chromosome 7 is involved in most aberrations. A JAZF1/PHF1 fusion gene was recently found in two tumors showing an exchange between 6p and 7p rearrangement. In the present study, we show that a low-grade ESS cell line carrying a der(7)t(6;7)(p21;p22) also harbors the a JAZF1/PHF1 fusion. In the fusion transcript, exon 3 of JAZF1 was fused with exon 2 of PHF1. At the junction, there was an insertion of 26 nucleotides, originating from intron 3 of JAZF1, thus maintaining an open reading frame of the chimeric transcript. The predicted 684-amino acid JAZF1/PHF1 chimeric protein retained one zinc finger domain from JAZF1 and the two zinc finger domains from PHF1, and its oncogenic mechanism should be similar to that of the JAZF1/SUZ12 protein. The present cell line constitutes an excellent model for further studies on the impact of the JAZF1/PHF1 fusion.

References

May 1, 1992·Cancer Genetics and Cytogenetics·A E FresiaC A Griffin
Oct 1, 1995·Cancer Genetics and Cytogenetics·L FüzesiM C Karl
Feb 15, 1993·Cancer·R LaxmanC A Griffin
May 21, 1999·Virchows Archiv : an International Journal of Pathology·R Gil-BensoA Llombart-Bosch
May 24, 2001·Proceedings of the National Academy of Sciences of the United States of America·J I KoontzJ Sklar
Aug 24, 2001·International Journal of Cancer. Journal International Du Cancer·I PanagopoulosN Mandahl
Jul 3, 2004·Genes & Development·Antonis KirmizisPeggy J Farnham
Aug 11, 2004·Nucleic Acids Research·Takeshi NakajimaAnton M Jetten
May 27, 2005·Current Biology : CB·Nathan D MontgomeryTerry Magnuson
Nov 15, 2007·Cytogenetic and Genome Research·A A Sandberg
Nov 15, 2007·Cytogenetic and Genome Research·F Micci, S Heim
Dec 19, 2007·Molecular and Cellular Biology·Ru CaoYi Zhang

❮ Previous
Next ❯

Citations

Feb 26, 2013·Archives of Gynecology and Obstetrics·Shin-ichi IwasakiRyuichiro Nishimura
Nov 15, 2012·The Journal of Biological Chemistry·Yang YangLong Yu
Apr 7, 2010·Obstetrics and Gynecology International·Norasate SamarnthaiI-Tien Yeh
Feb 18, 2016·Orphanet Journal of Rare Diseases·Andelko Hrzenjak
Mar 23, 2011·Human Pathology·Sarah Chiang, Esther Oliva
Feb 15, 2011·Human Pathology·Catalina Amador-OrtizJohn D Pfeifer
Dec 1, 2009·Surgical Pathology Clinics·Cheng-Han LeeC Blake Gilks
Oct 2, 2014·The FEBS Journal·Pedro VizánLuciano Di Croce
Nov 16, 2010·Developmental Cell·María Berdasco, Manel Esteller
Aug 16, 2016·Surgical Pathology Clinics·Lauren L Ritterhouse, Brooke E Howitt
Apr 27, 2017·Current Opinion in Oncology·Rainer Hamacher, Sebastian Bauer
Apr 17, 2018·Cancer Science·Hideaki Tsuyoshi, Yoshio Yoshida
Aug 21, 2020·Genes, Chromosomes & Cancer·Yusuke NomuraDaichi Maeda
Nov 19, 2009·Acta Orthopaedica. Supplementum·Thor AlvegårdAnders Rydholm
May 16, 2019·Nature Communications·Siddhant U JainPeter W Lewis
Aug 24, 2021·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Sara D A AngioneClinton F Stewart
Aug 21, 2021·Journal of Zhejiang University. Science. B·Chunhui Li, Chunhong Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.